Insights of [18F]FDG and [18F]-DOPA to assess striatal fiber status through PET/MR in living rodents under neuroprotective treatment

被引：0
|
作者：
Ravasi, L. [1 ]
Laloux, C. [2 ]
Petrault, M. [2 ]
Auger, F. [1 ]
Durieux, N. [3 ]
Devos, D. [2 ]
Bordet, R. [2 ]
机构：
[1] EA 1046, Plateforme Imagerie Vivant IMPRT IFR 114, Lille, France
[2] Univ Lille, EA Pharmacol 1046, Lille, France
[3] Plateforme Imagerie Vivant IMPRT IFR 114, Lille, France
来源：
FUNDAMENTAL & CLINICAL PHARMACOLOGY | 2014年 / 28卷
关键词：
small animal PET; Parkinson's disease; FDG; FDOPA;
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：37 / 37
页数：1
相关论文
共 50 条
  • [21] Diagnostic impact of PET with 18F-FDG, 18F-DOPA and 3-O-methyl-6-[18F]fluoro-DOPA in recurrent or metastatic medullary thyroid carcinoma
    B. Beuthien-Baumann
    A. Strumpf
    J. Zessin
    J. Bredow
    J. Kotzerke
    European Journal of Nuclear Medicine and Molecular Imaging, 2007, 34 : 1604 - 1609
  • [22] [18F]FDG uptake of the normal spinal cord in PET/MR imaging: comparison with PET/CT imaging
    Marco Aiello
    Vincenzo Alfano
    Elena Salvatore
    Carlo Cavaliere
    Marco Picardi
    Roberta Della Pepa
    Emanuele Nicolai
    Andrea Soricelli
    Alessandra Vella
    Marco Salvatore
    Mario Mascalchi
    EJNMMI Research, 10
  • [23] [18F]FDG uptake of the normal spinal cord in PET/MR imaging: comparison with PET/CT imaging
    Aiello, Marco
    Alfano, Vincenzo
    Salvatore, Elena
    Cavaliere, Carlo
    Picardi, Marco
    Della Pepa, Roberta
    Nicolai, Emanuele
    Soricelli, Andrea
    Vella, Alessandra
    Salvatore, Marco
    Mascalchi, Mario
    EJNMMI RESEARCH, 2020, 10 (01)
  • [24] Prospective Evaluation of 99mTc MDP Scintigraphy, 18F NaF PET/CT, and 18F FDG PET/CT for Detection of Skeletal Metastases
    Iagaru, Andrei
    Mittra, Erik
    Dick, David W.
    Gambhir, Sanjiv Sam
    MOLECULAR IMAGING AND BIOLOGY, 2012, 14 (02) : 252 - 259
  • [25] Comparison of simultaneous18F-2-[18F] FDG PET/MR and PET/CT in the follow-up of patients with differentiated thyroid cancer
    Klain, Michele
    Nappi, Carmela
    Nicolai, Emanuele
    Romeo, Valeria
    Piscopo, Leandra
    Giordano, Alessia
    Gaudieri, Valeria
    Zampella, Emilia
    Pace, Leonardo
    Carlo, Cavaliere
    Salvatore, Marco
    Schlumberger, Martin
    Cuocolo, Alberto
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (13) : 3066 - 3073
  • [26] The diagnostic performance of [18F]FET PET/MRI versus [18F]FDG PET/MRI for recurrent glioma: a systematic review and meta-analysis
    Huo, Huasong
    Shen, Shurui
    Zhang, Lanyue
    Yang, Fuwei
    Li, Yunqian
    CLINICAL AND TRANSLATIONAL IMAGING, 2023, 11 (03) : 285 - 295
  • [27] Comparison of simultaneous 18F-2-[18F] FDG PET/MR and PET/CT in the follow-up of patients with differentiated thyroid cancer
    Michele Klain
    Carmela Nappi
    Emanuele Nicolai
    Valeria Romeo
    Leandra Piscopo
    Alessia Giordano
    Valeria Gaudieri
    Emilia Zampella
    Leonardo Pace
    Cavaliere Carlo
    Marco Salvatore
    Martin Schlumberger
    Alberto Cuocolo
    European Journal of Nuclear Medicine and Molecular Imaging, 2020, 47 : 3066 - 3073
  • [28] [18F]FDG-PET CT for the evaluation of native valve endocarditis
    Abikhzer, Gad
    Martineau, Patrick
    Gregoire, Jean
    Finnerty, Vincent
    Harel, Francois
    Pelletier-Galarneau, Matthieu
    JOURNAL OF NUCLEAR CARDIOLOGY, 2022, 29 (01) : 158 - 165
  • [29] Head-to-Head comparison of [18F]FES and [18F]FDG PET/CT in breast cancer patients: has a new era come?
    Guglielmo, Priscilla
    Mazzola, Rosario
    Darwish, Shadya Sara
    Valenti, Francesco
    De Pas, Tommaso Martino
    Setti, Lucia
    Bonacina, Manuela
    Grassi, Massimo Maria
    Evangelista, Laura
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2025, : 2710 - 2722
  • [30] [18F]FDG PET/CT of Langerhans Cell Histiocytosis with Vertebra Plana
    Speicher, Tilman
    Bastian, Moritz B.
    Christofyllakis, Konstantinos
    Rosar, Florian
    Ezziddin, Samer
    Burgard, Caroline
    DIAGNOSTICS, 2025, 15 (07)
12345